The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.

Discussion The results of this analysis demonstrate that overall, the likelihood of patients maintaining remission or LDA following dose reduction or discontinuation of etanercept follows a significant trend, with those initially achieving sustained deep remission being the most likely to maintain a response, followed by those achieving deep remission and sustained remission.

also in 9,775 other papers